机构

• 上海药物研究所 [24]
• 合肥物质科学研究院 [5]
• 成都生物研究所 [2]
• 海洋研究所 [2]
• 近代物理研究所 [2]
• 昆明植物研究所 [1]
• 更多

采集方式

• OAI收割 [38]

内容类型

• 期刊论文 [36]
• 会议论文 [1]
• 学位论文 [1]

发表日期

• 2024 [1]
• 2023 [4]
• 2022 [6]
• 2021 [5]
• 2020 [5]
• 2019 [3]
• 更多

学科主题

• 天然产物研究 [2]
• Biochemist... [1]
• Plant Scie... [1]

筛选

浏览/检索结果: 共38条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging 期刊论文  OAI收割 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 页码: 14 作者:  He, Chunfeng;  Shi, Hui;  Tan, Boyu;  Jiang, Zhaoning;  Cao, Rui   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/08/22 PARP  Oncology  Quinazoline-2,4(1H,3H)-dione  PET/CT   Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19 作者:  Wang, Pingyuan;  Zhu, Wen-Ting;  Wang, Yajing;  Song, Shan-Shan;  Xi, Yong   |  收藏  |  浏览/下载：70/0  |  提交时间：2023/10/17 PARP1 inhibitor  Synthetic lethality  Drug resistance  Anticancer  Structure -activity relationship   Advancements and Obstacles of PARP Inhibitors in Gastric Cancer 期刊论文  OAI收割 CANCERS, 2023, 卷号: 15, 期号: 21, 页码: 19 作者:  Chen, Hongjie;  Hu, Yangchan;  Zhuang, Zirui;  Wang, Dingyi;  Ye, Zu   |  收藏  |  浏览/下载：17/0  |  提交时间：2023/12/19 gastric cancer  DNA damage repair  PARP inhibitor  cancer therapy   Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance 期刊论文  OAI收割 EMBO MOLECULAR MEDICINE, 2023, 页码: 24 作者:  Wang, Li-Min;  Wang, Pingyuan;  Chen, Xiao-Min;  Yang, Hui;  Song, Shan-Shan   |  收藏  |  浏览/下载：51/0  |  提交时间：2023/04/10 homologous recombination repair  olaparib-resistant  PARP inhibitor  PARP7  type I interferons   Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancers 期刊论文  OAI收割 AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 卷号: 13, 期号: 1, 页码: 161-+ 作者:  Li, Yongpeng;  Li, Lin;  Fu, Haoyu;  Yao, Qing;  Wang, Lei   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/10/17 Antibody-drug conjugate  DS-8201  PARP  ATR  synergy  DNA damage   Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han   |  收藏  |  浏览/下载：48/0  |  提交时间：2022/12/22 small-cell lung cancer  H3  3  PARP1  PARP inhibitor  darinaparsin  combination treatment   Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 240, 页码: 114574 作者:  Kayumov, Muzaffar;  Jia, Li;  Pardaev, Azizbek;  Song, Shan-Shan;  Mirzaakhmedov, Sharafitdin   |  收藏  |  浏览/下载：35/0  |  提交时间：2024/03/21 PARP1  Olaparib  Alantolactone  Syntheticlethality  BRCA1/2mutant   Vanguard is a Glucose Deprivation-Responsive Long Non-Coding RNA Essential for Chromatin Remodeling-Reliant DNA Repair 期刊论文  OAI收割 ADVANCED SCIENCE, 2022 作者:  Zhang, Ben;  Thorne, Rick Francis;  Zhang, Pengfei;  Wu, Mian;  Liu, Lianxin   |  收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23 genomic stability  HMGB1  long non-coding RNAs  PARP inhibitors  Vanguard   Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文  OAI收割 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022 作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge   |  收藏  |  浏览/下载：66/0  |  提交时间：2022/05/05 BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor   Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancers 期刊论文  OAI收割 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 页码: 14 作者:  Bian, Yicong;  Meng, Jian;  Ma, Sheng;  Li, Guangze;  Wang, Yuya   |  收藏  |  浏览/下载：104/0  |  提交时间：2022/06/15 fuzuloparib  mass balance  metabolite profiles  PARP  pharmacokinetics